Ephrin­B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis­free survival in breast cancer.

Magic, Zeljana; Sandström, Josefine; Perez-Tenorio, Gizeh

EphrinB2 inhibits cell proliferation and motility in vitro and predicts longer metastasisfree survival in breast cancer.

Magic, Zeljana; Sandström, Josefine; Perez-Tenorio, Gizeh.

Affiliation

Magic Z; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE58185 Linköping, Sweden.
Sandström J; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE58185 Linköping, Sweden.
Perez-Tenorio G; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE58185 Linköping, Sweden.

Int J Oncol ; 55(6): 1275-1286, 2019 Dec.

Article in En | MEDLINE | ID: mdl-31638179

Subject(s)

Breast Neoplasms/mortality; Breast/pathology; Ephrin-B2/metabolism; Neoplasm Recurrence, Local/diagnosis; Receptor, EphB4/metabolism; Breast Neoplasms/pathology; Breast Neoplasms/therapy; Cell Movement; Cell Proliferation; Datasets as Topic; Disease-Free Survival; Ephrin-B2/analysis; Ephrin-B2/genetics; Female; Humans; Kaplan-Meier Estimate; MCF-7 Cells; Neoplasm Recurrence, Local/pathology; Prognosis; RNA, Small Interfering/metabolism; Randomized Controlled Trials as Topic; Receptor, EphB4/analysis; Receptor, EphB4/genetics; Time Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast / Breast Neoplasms / Receptor, EphB4 / Ephrin-B2 / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google